2016
DOI: 10.30809/phe.1.2016.29
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacoeconomic analysis of lapatinib treatment in metastatic breast cancer with HER2+ overexpression

Abstract: According to the World Health Organization, breast cancer is the most common form of cancer in women worldwide. The steady increase in

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 10 publications
(20 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?